Julian R Molina, MD, PhD

  • 8096 Citations
  • 36 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1996 2019

  • 8096 Citations
  • 36 Scopus h-Index
  • 109 Article
  • 2 Review article
  • 1 Chapter
  • 1 Editorial
2019
3 Citations (Scopus)

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Duma, N., Santana-Davila, R. & Molina, J. R., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1623-1640 18 p.

Research output: Contribution to journalReview article

Open Access
Early Detection of Cancer
Non-Small Cell Lung Carcinoma
Programmed Cell Death 1 Receptor
Epidemiology
Lung Neoplasms

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

Russell, S. J., Babovic-Vuksanovic, D., Bexon, A., Cattaneo, R., Dingli, D., Dispenzieri, A., Deyle, D. R., Federspiel, M. J., Fielding, A., Galanis, E., Lacy, M. Q., Leibovich, B. C., Liu, M. C., Muñoz-Alía, M., Miest, T. C., Molina, J. R., Mueller, S., Okuno, S. H., Packiriswamy, N., Peikert, T. & 6 others, Raffel, C., Van Rhee, F., Ungerechts, G., Young, P. R., Zhou, Y. & Peng, K. W., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalReview article

Open Access
Oncolytic Virotherapy
Measles
Vaccination
Measles virus
Immunity
1 Citation (Scopus)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

Sarkar Bhattacharya, S., Thirusangu, P., Jin, L., Roy, D., Jung, D., Xiao, Y., Staub, J., Roy, B., Molina, J. R. & Shridhar, V., Oct 1 2019, In : Cell Death and Disease. 10, 10, 725.

Research output: Contribution to journalArticle

Open Access
Phosphofructokinase-2
Endoplasmic Reticulum Stress
Fructose
Food
Cell Death
26 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio
11 Citations (Scopus)

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: An updated analysis of keynote-010 trial

Herbst, R. S., Baas, P., Perez-Gracia, J. L., Felip, E., Kim, D. W., Han, J. Y., Molina, J. R., Kim, J. H., Dubos Arvis, C., Ahn, M. J., Majem, M., Fidler, M. J., Surmont, V., De Castro, G., Garrido, M., Shentu, Y., Emancipator, K., Samkari, A., Jensen, E. H., Lubiniecki, G. M. & 1 others, Garon, E. B., Feb 1 2019, In : Annals of Oncology. 30, 2, p. 281-289 9 p.

Research output: Contribution to journalArticle

docetaxel
Confidence Intervals
Survival
Neoplasms
Proteins
2018
tipifarnib
Farnesyltranstransferase
Epidermal Growth Factor
Protein-Tyrosine Kinases
Maximum Tolerated Dose
1 Citation (Scopus)
Pemetrexed
Vascular Endothelial Growth Factor A
Maximum Tolerated Dose
Neoplasms
Proto-Oncogene Proteins c-kit
Pharmacokinetics
Protein-Tyrosine Kinases
Appointments and Schedules
Safety
Maximum Tolerated Dose
5 Citations (Scopus)

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma

Lee, H. E., Molina, J. R., Sukov, W. R., Roden, A. & Yi, E. S., Sep 1 2018, In : Human Pathology. 79, p. 168-176 9 p.

Research output: Contribution to journalArticle

BRCA1 Protein
Mesothelioma
Adenomatoid Tumor
Fluorescence In Situ Hybridization
Malignant Mesothelioma
1 Citation (Scopus)

Carcinoid Heart Disease in Patients With Bronchopulmonary Carcinoid

De Jesus, T., Luis, S. A., Ryu, J. H., Molina, J. R., Connolly, H. M., Maleszewski, J. & Pellikka, P., Oct 1 2018, In : Journal of Thoracic Oncology. 13, 10, p. 1602-1605 4 p.

Research output: Contribution to journalArticle

Carcinoid Heart Disease
Carcinoid Tumor
Patent Foramen Ovale
Pulmonary Valve
Tricuspid Valve
1 Citation (Scopus)

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Duma, N., Kothadia, S. M., Azam, T. U., Yadav, S., Paludo, J., Vera Aguilera, J., Gonzalez Velez, M., Halfdanarson, T. R., Molina, J. R., Hubbard, J. M., Go, R. S., Mansfield, A. & Adjei, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Patient Selection
Comorbidity
Clinical Trials
Central Nervous System
Neoplasm Metastasis
1 Citation (Scopus)

Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion

Ren, H., Hou, X., Eiken, P. W., Zhang, J., Pierson, K. E., Nair, A. A., Davila, J. I., Kovarikova, H., Jang, J. S., Johnson, S. H., Molina, J. R., Marks, R. S., Yang, P., Yi, J. E., Mansfield, A. & Jen, J., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

SCID Mice
Gene Fusion
Adenocarcinoma of lung
13 Citations (Scopus)

NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

Kalemkerian, G. P., Loo, B. W., Akerley, W., Attia, A., Bassetti, M., Boumber, Y., Decker, R., Dobelbower, M. C., Dowlati, A., Downey, R. J., Florsheim, C., Ganti, A. K. P., Grecula, J. C., Gubens, M. A., Hann, C. L., Hayman, J. A., Heist, R. S., Koczywas, M., Merritt, R. E., Mohindra, N. & 11 others, Molina, J. R., Moran, C. A., Morgensztern, D., Pokharel, S., Portnoy, D. C., Rhodes, D., Rusthoven, C., Santana-Davila, R., Williams, C. C., Hoffmann, K. G. & Hughes, M., Oct 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 10, p. 1171-1182 12 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Guidelines
Disease Management
Immunotherapy
Signs and Symptoms
4 Citations (Scopus)

Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers

Xie, D., Allen, M. S., Marks, R. S., Jiang, G., Sun, Z. D., Nichols, F., Zhang, M., Chen, C., Aubry, M. C., Jatoi, A., Garces, Y. I., Mansfield, A., Wigle, D. A., Molina, J. R., Deschamps, C. & Yang, P., Jun 1 2018, In : European Journal of Cardio-thoracic Surgery. 53, 6, p. 1214-1222 9 p.

Research output: Contribution to journalArticle

Nomograms
Non-Small Cell Lung Carcinoma
Survival
Proportional Hazards Models
Monocytes
7 Citations (Scopus)

Pathways impacted by genomic alterations in pulmonary carcinoid tumors

Asiedu, M. K., Thomas, C. F., Dong, J., Schulte, S. C., Khadka, P., Sun, Z. D., Kosari, F., Jen, J., Molina, J. R., Vasmatzis, G., Kuang, R., Aubry, M. C., Yang, P. & Wigle, D. A., Apr 1 2018, In : Clinical Cancer Research. 24, 7, p. 1691-1704 14 p.

Research output: Contribution to journalArticle

Carcinoid Tumor
Lung
Neoplasm Genes
Biological Phenomena
Exome
7 Citations (Scopus)

Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients

Maneenil, K., Xue, Z., Liu, M., Boland, J., Wu, F., Stoddard, S. M., Molina, J. R. & Yang, P., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Carcinoma
Lung
Confidence Intervals
Drug Therapy
Non-Small Cell Lung Carcinoma
2 Citations (Scopus)

Smoking, sex, and non–Small cell lung cancer: Steroid hormone receptors in tumor tissue (S0424)

Cheng, T. Y. D., Darke, A. K., Redman, M. W., Zirpoli, G. R., Davis, W., Ondracek, R. P., Bshara, W., Omilian, A. R., Kratzke, R., Reid, M. E., Molina, J. R., Kolesar, J. M., Chen, Y., MacRae, R. M., Moon, J., Mack, P., Gandara, D. R., Kelly, K., Santella, R. M., Albain, K. S. & 1 others, Ambrosone, C. B., Jan 1 2018, In : Journal of the National Cancer Institute. 110, 7, p. 734-742 9 p.

Research output: Contribution to journalArticle

Steroid Receptors
Non-Small Cell Lung Carcinoma
Estrogen Receptors
Smoking
Hormones
2017
12 Citations (Scopus)

A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors

Haddad, T. C., Qin, R., Lupu, R., Satele, D., Eadens, M., Goetz, M. P., Erlichman, C. & Molina, J. R., Jun 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 6, p. 1221-1227 7 p.

Research output: Contribution to journalArticle

Paclitaxel
Tumors
Neoplasms
Clinical Trials, Phase I
Maximum Tolerated Dose
7 Citations (Scopus)

A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness

Yan, F., Shen, N., Pang, J., Zhao, N., Deng, B., Li, B., Yang, Y. D., Yang, P., Molina, J. R. & Liu, S., Dec 14 2017, In : Oncogene. 36, 50, p. 6919-6928 10 p.

Research output: Contribution to journalArticle

Methyltransferases
Protein-Tyrosine Kinases
Lung Neoplasms
DNA Methylation
Carcinogenesis

Digit-a tool for detection and identification of genomic interchromosomal translocations

Meier, R., Graw, S., Beyerlein, P., Koestler, D., Molina, J. R. & Chien, J., May 19 2017, In : Nucleic Acids Research. 45, 9, p. e72

Research output: Contribution to journalArticle

Workflow
Genomic Structural Variation
Cataloging
Genetic Translocation
Artifacts

Editorial: Pleural recurrence of thymoma-what is the value of intra-thoracic chemo-hyperthermia?

Roden, A. & Molina, J. R., Oct 1 2017, In : Journal of Thoracic Disease. 9, 10, p. 3583-3586 4 p.

Research output: Contribution to journalEditorial

Thymoma
Fever
Thorax
Recurrence
7 Citations (Scopus)

Management of Multifocal Lung Cancer: Results of a Survey

Leventakos, K., Peikert, T. D., Midthun, D. E., Molina, J. R., Blackmon, S., Nichols, F. C., Garces, Y. I., Hallemeier, C., Murphy, S. J., Vasmatzis, G., Kratz, S. L., Holland, W. P., Thomas, C. F., Mullon, J. J., Shen, K. R., Cassivi, S. D., Marks, R. S., Aubry, M. C., Adjei, A., Yang, P. & 4 others, Allen, M. S., Edell, E., Wigle, D. A. & Mansfield, A., 2017, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Lung Neoplasms
Neoplasm Metastasis
Mediastinoscopy
Mediastinum
Bronchoscopy
21 Citations (Scopus)

Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance)

Edelman, M. J., Wang, X., Hodgson, L., Cheney, R. T., Baggstrom, M. Q., Thomas, S. P., Gajra, A., Bertino, E., Reckamp, K. L., Molina, J. R., Schiller, J. H., Mitchell-Richards, K., Friedman, P. N., Ritter, J., Milne, G., Hahn, O. M., Stinchcombe, T. E. & Vokes, E. E., Jul 1 2017, In : Journal of Clinical Oncology. 35, 19, p. 2184-2192 9 p.

Research output: Contribution to journalArticle

Celecoxib
Cyclooxygenase 2
Non-Small Cell Lung Carcinoma
Leukemia
Placebos
20 Citations (Scopus)

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

Prasongsook, N., Kumar, A., Chintakuntlawar, A., Foote, R. L., Kasperbauer, J., Molina, J. R., Garces, Y. I., Ma, D., Wittich, M. A. N., Rubin, J., Richardson, R., Morris, J., Hay, I. D., Fatourechi, V., McIver, B., Ryder, M., Thompson, G., Grant, C., Richards, M., Sebo, T. J. & 5 others, Rivera, M., Suman, V. J., Jenkins, S. M., Smallridge, R. C. & Bible, K. C., Dec 1 2017, In : The Journal of clinical endocrinology and metabolism. 102, 12, p. 4506-4514 9 p.

Research output: Contribution to journalArticle

Hazards
Survival
Palliative Care
Confidence Intervals
Therapeutics
2016
1 Citation (Scopus)

88P: Use of brain imaging in the management of patients with lymph node negative multifocal lung cancer

Leventakos, K., Mansfield, A., Blackmon, S., Cassivi, S., Shen, R., Nichols, F. C., Molina, J. R., Allen, M. S., Aubry, M. C. & Wigle, D. A., Apr 1 2016, In : Journal of Thoracic Oncology. 11, 4, p. S93-S94

Research output: Contribution to journalArticle

Neuroimaging
Lung Neoplasms
Lymph Nodes
25 Citations (Scopus)

A first-in-human phase i study of the oral p38 MAPK inhibitor, ralimetinib (LY2228820 Dimesylate), in patients with advanced cancer

Patnaik, A., Haluska, P., Tolcher, A. W., Erlichman, C., Papadopoulos, K. P., Lensing, J. L., Beeram, M., Molina, J. R., Rasco, D. W., Arcos, R. R., Kelly, C. S., Wijayawardana, S. R., Zhang, X., Stancato, L. F., Bell, R., Shi, P., Kulanthaivel, P., Pitou, C., Mulle, L. B., Farrington, D. L. & 2 others, Chan, E. M. & Goetz, M. P., Mar 1 2016, In : Clinical Cancer Research. 22, 5, p. 1095-1102 8 p.

Research output: Contribution to journalArticle

LY2228820
p38 Mitogen-Activated Protein Kinases
Tamoxifen
Neoplasms
Safety
26 Citations (Scopus)

A genetic cell context-dependent role for ZEB1 in lung cancer

Zhang, T., Guo, L., Creighton, C. J., Lu, Q., Gibbons, D. L., Yi, E. S., Deng, B., Molina, J. R., Sun, Z. D., Yang, P. & Yang, Y. D., Jul 26 2016, In : Nature Communications. 7, 12231.

Research output: Contribution to journalArticle

lungs
boxes
Zinc
Lung Neoplasms
zinc
5 Citations (Scopus)

C-Met expression and MET amplification in malignant pleural mesothelioma

Bois, M. C., Mansfield, A., Sukov, W. R., Jenkins, S. M., Moser, J. C., Sattler, C. A., Smith, C. Y., Molina, J. R., Peikert, T. D. & Roden, A., Aug 1 2016, In : Annals of Diagnostic Pathology. 23, p. 1-7 7 p.

Research output: Contribution to journalArticle

Staining and Labeling
Malignant Mesothelioma
Surgical Pathology
Chromosomes, Human, Pair 7
Survival
54 Citations (Scopus)

Comprehensive genomic profiling identifies a subset of Crizotinib- responsive ALK-rearranged non-small cell lung cancer not detected by fluorescence in situ hybridization

Ali, S. M., Hensing, T., Schrock, A. B., Allen, J., Sanford, E., Gowen, K., Kulkarni, A., He, J., Suh, J. H., Lipson, D., Elvin, J. A., Yelensky, R., Chalmers, Z., Chmielecki, J., Peled, N., Klempner, S. J., Firozvi, K., Frampton, G. M., Molina, J. R., Amenon, S. & 14 others, Brahmer, J. R., MacMahon, H., Nowak, J., Ignatius Ou, S. H., Zauderer, M., Ladanyi, M., Zakowski, M., Fischbach, N., Ross, J. S., Stephens, P. J., Miller, V. A., Wakelee, H., Ganesan, S. & Salgia, R., Jun 1 2016, In : Oncologist. 21, 6, p. 762-770 9 p.

Research output: Contribution to journalArticle

Fluorescence In Situ Hybridization
Non-Small Cell Lung Carcinoma
United States Food and Drug Administration
Standard of Care
crizotinib
36 Citations (Scopus)

DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53

Alam, S. K., Yadav, V. K., Bajaj, S., Datta, A., Dutta, S. K., Bhattacharyya, M., Bhattacharya, S., Debnath, S., Roy, S., Boardman, L. A., Smyrk, T. C., Molina, J. R., Chakrabarti, S., Chowdhury, S., Mukhopadhyay, D. & Roychoudhury, S., Apr 1 2016, In : Cell Death and Differentiation. 23, 4, p. 707-722 16 p.

Research output: Contribution to journalArticle

Ephrin-B2
Epithelial-Mesenchymal Transition
DNA Damage
Colorectal Neoplasms
p53 Genes
22 Citations (Scopus)

Elevated cellular PD1/PD-L1 expression confers acquired resistance to cisplatin in small cell lung cancer cells

Yan, F., Pang, J., Peng, Y., Molina, J. R., Yang, P. & Liu, S., Sep 1 2016, In : PLoS One. 11, 9, e0162925.

Research output: Contribution to journalArticle

cisplatin
Small Cell Lung Carcinoma
lung neoplasms
Cisplatin
Cells
2185 Citations (Scopus)

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial

Herbst, R. S., Baas, P., Kim, D. W., Felip, E., Pérez-Gracia, J. L., Han, J. Y., Molina, J. R., Kim, J. H., Arvis, C. D., Ahn, M. J., Majem, M., Fidler, M. J., De Castro, G., Garrido, M., Lubiniecki, G. M., Shentu, Y., Im, E., Dolled-Filhart, M. & Garon, E. B., Apr 9 2016, In : The Lancet. 387, 10027, p. 1540-1550 11 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Randomized Controlled Trials
Disease-Free Survival
Neoplasms

Response of uveal metastases to alk inhibitors in alk-positive non-small-cell lung cancer

Abdellatief, A., Molina, J. R. & Pulido, J. S., Jan 1 2016, In : Retinal Cases and Brief Reports. 10, 1, p. 37-40 4 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
anaplastic lymphoma kinase
Bronchi
Adenocarcinoma
2015
23 Citations (Scopus)

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells

Hoeppner, L. H., Wang, Y., Sharma, A., Javeed, N., Van Keulen, V. P., Wang, E., Yang, P., Roden, A., Peikert, T. D., Molina, J. R. & Mukhopadhyay, D., Jan 1 2015, In : Molecular Oncology. 9, 1, p. 270-281 12 p.

Research output: Contribution to journalArticle

Dopamine D2 Receptors
Dopamine Agonists
Lung Neoplasms
Neoplasms
Lung
45 Citations (Scopus)

First-in-human study of PF-05212384 (PKI-587), a small-molecule, intravenous, dual inhibitor of PI3K and mTOR in patients with advanced cancer

Shapiro, G. I., Bell-McGuinn, K. M., Molina, J. R., Bendell, J., Spicer, J., Kwak, E. L., Pandya, S. S., Millham, R., Borzillo, G., Pierce, K. J., Han, L., Houk, B. E., Gallo, J. D., Alsina, M., Braña, I. & Tabernero, J., Apr 15 2015, In : Clinical Cancer Research. 21, 8, p. 1888-1895 8 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Maximum Tolerated Dose
Neoplasms
Pharmacokinetics
Therapeutics
35 Citations (Scopus)
Nomograms
Small Cell Lung Carcinoma
Survival
Lymphocytes
Erythrocyte Indices
1 Citation (Scopus)

Pulmonary artery agenesis associated with emphysema and multiple invasive non-small cell lung cancers

Makdisi, G., Edell, E., Maleszewski, J., Molina, J. R. & Deschamps, C., Jun 1 2015, In : Annals of Thoracic Surgery. 99, 6, p. 2192-2195 4 p.

Research output: Contribution to journalArticle

Emphysema
Non-Small Cell Lung Carcinoma
Pulmonary Artery
Literature
Hemoptysis
19 Citations (Scopus)
4'-N-benzoylstaurosporine
decitabine
Methyltransferases
Protein-Tyrosine Kinases
Lung Neoplasms
2014
32 Citations (Scopus)

Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma

Geiger, J. L., Lazim, A. F., Walsh, F. J., Foote, R. L., Moore, E. J., Okuno, S. H., Olsen, K. D., Kasperbauer, J., Price, D. L., Garces, Y. I., Ma, D. J., Neben-Wittich, M. A., Molina, J. R., Garcia, J. J. & Price, K. A. R., 2014, In : Oral Oncology. 50, 4, p. 311-318 8 p.

Research output: Contribution to journalArticle

Cisplatin
Survival
Oropharyngeal Neoplasms
Therapeutics
Oropharynx
54 Citations (Scopus)

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H

Bible, K. C., Suman, V. J., Molina, J. R., Smallridge, R. C., Maples, W. J., Menefee, M. E., Rubin, J., Karlin, N., Sideras, K., Morris, J. C., McIver, B., Hay, I. D., Fatourechi, V., Burton, J. K., Webster, K. P., Bieber, C., Traynor, A. M., Flynn, P. J., Goh, B. C., Isham, C. R. & 2 others, Harris, P. & Erlichman, C., 2014, In : Journal of Clinical Endocrinology and Metabolism. 99, 5, p. 1687-1693 7 p.

Research output: Contribution to journalArticle

Tumors
Vascular Endothelial Growth Factor Receptor-1
Platelet-Derived Growth Factor Receptors
Disease Progression
Liver
20 Citations (Scopus)

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321

Zhao, Y., Foster, N. R., Meyers, J. P., Thomas, S. P., Northfelt, D. W., Rowland, K. M., Mattar, B. I., Johnson, D. B., Molina, J. R., Mandrekar, S. J., Schild, S. E., Bearden, J. D., Aubry, M. C. & Adjei, A., Sep 22 2014, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Radiotherapy
Thorax
22 Citations (Scopus)

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

Molina, J. R., Foster, N. R., Reungwetwattana, T., Nelson, G. D., Grainger, A. V., Steen, P. D., Stella, P. J., Marks, R. S., Wright, J. & Adjei, A., 2014, In : Lung Cancer. 85, 2, p. 245-250 6 p.

Research output: Contribution to journalArticle

src-Family Kinases
Small Cell Lung Carcinoma
Drug Therapy
Disease-Free Survival
Survival Rate
6 Citations (Scopus)

Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA

Deng, B., Molina, J. R., Aubry, M. C., Sun, Z. D., Wang, L., Eckloff, B. W., Vasmatzis, G., You, M., Wieben, E. D., Jen, J., Wigle, D. A. & Yang, P., Jul 9 2014, In : Cell and Bioscience. 4, 1, 35.

Research output: Contribution to journalArticle

Carcinoid Tumor
Biomarkers
MicroRNAs
Tumors
Genes
15 Citations (Scopus)

Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: A comprehensive genetic profiling and survival analysis

Sio, T. T., Mansfield, A., Grotz, T. E., Graham, R., Molina, J. R., Que, F. & Miller, R. C., 2014, In : Journal of Human Genetics. 59, 3, p. 124-128 5 p.

Research output: Contribution to journalArticle

Pseudomyxoma Peritonei
Survival Analysis
Mutation
Neoplasm Genes
Codon
8 Citations (Scopus)

NCCTG N0821 (Alliance): A phase ii first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status

Dy, G. K., Molina, J. R., Qi, Y., Ansari, R., Thomas, S., Ross, H. J., Soori, G., Anderson, D., Christine Aubry, M., Meyers, J., Adjei, A. A., Mandrekar, S. J. & Adjei, A., 2014, In : Journal of Thoracic Oncology. 9, 8, p. 1146-1153 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Non-Small Cell Lung Carcinoma
Quality of Life
Confidence Intervals
41 Citations (Scopus)

Restoration ofmiR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation

Yan, F., Shen, N., Pang, J., Xie, D., Deng, B., Molina, J. R., Yang, P. & Liu, S., Jan 1 2014, In : Cell Death and Disease. 5, 9, e1413.

Research output: Contribution to journalArticle

DNA Methylation
Carcinogenesis
Lung Neoplasms
Lung
decitabine
2013
33 Citations (Scopus)

A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North central cancer treatment group study N0528

Adjei, A., Dy, G. K., Mandrekar, S. J., Nelson, G. D., Meyers, J. P., Adjei, A. A., Ross, H. J., Ansari, R. H., Lyss, A. P., Stella, P. J., Schild, S. E. & Molina, J. R., Jan 2013, In : Journal of Thoracic Oncology. 8, 1, p. 79-88 10 p.

Research output: Contribution to journalArticle

gemcitabine
Carboplatin
Non-Small Cell Lung Carcinoma
Neoplasms
Survival
9 Citations (Scopus)

Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts

Khurana, A., Jung-Beom, D., He, X., Kim, S. H., Busby, R. C., Lorenzon, L., Villa, M., Baldi, A., Molina, J. R., Goetz, M. P. & Shridhar, V., Apr 2013, In : Clinical and Experimental Metastasis. 30, 4, p. 407-415 9 p.

Research output: Contribution to journalArticle

Sulfatases
Heterografts
Breast Neoplasms
Cell Line
Cell Death
19 Citations (Scopus)

NUT midline carcinoma: An aggressive intrathoracic neoplasm

Parikh, S. A., French, C. A., Costello, B., Marks, R. S., Dronca, R. S., Nerby, C. L., Roden, A., Peddareddigari, V. G., Hilton, J., Shapiro, G. I. & Molina, J. R., 2013, In : Journal of Thoracic Oncology. 8, 10, p. 1335-1338 4 p.

Research output: Contribution to journalArticle

Nuclear Proteins
Testis
Carcinoma
Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 15
9 Citations (Scopus)

Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies

Kumar, S. K., Jett, J., Marks, R. S., Richardson, R., Quevedo, F., Moynihan, T., Croghan, G., Markovic, S. N., Bible, K. C., Qin, R., Tan, A., Molina, J. R., Kaufmann, S. H., Erlichman, C. & Adjei, A., Oct 2013, In : Investigational New Drugs. 31, 5, p. 1201-1206 6 p.

Research output: Contribution to journalArticle

Neoplasms
Maximum Tolerated Dose
Proteasome Inhibitors
B-Cell Chronic Lymphocytic Leukemia
Adrenal Glands